YICHANG,China,Nov. 15,2024-- Angel Yeast has taken a significant step towards modernization and sustainability by automating its packaging line while ensuring no layoffs for its employees. In 2024,wi
Nov 18, 2024
GUANGZHOU,China,Nov. 15,2024-- MINISO,a leading global lifestyle brand known for its high-quality,affordable lifestyle products,is delighted that its Harry Potter-inspired collection is now available
Nov 18, 2024
HONG KONG,Nov. 15,2024-- ICZOOM Group Inc. (Nasdaq: IZM) (the "Company" or "ICZOOM"),a B2B electronic component products e-commerce platform,announced that ICZOOM and Hjet Supply C
Nov 18, 2024
BEIJING,Nov. 15,2024-- A news report byChina.org.cn on RMB internationalization:  
Nov 18, 2024
Five eminent speakers,including Nobel laureates and the top Chinese physicist Qi-Kun Xue,share groundbreaking insights at the Tencent WE Summit in Chengdu.
Nov 18, 2024
PLEASANTON,Calif.,Nov. 16,2024-- This Black Friday,DermRays is excited to announce its most significant sale of the year,offering $130 off sitewide from November 16-30th,2024. With this limited-time d
Nov 18, 2024
BEIJING,Nov. 18,2024-- Brazil officially assumed the one-year presidency of the G20 in December 2023,with the motto "Building a just world and a sustainable planet." This aligns with the com
Nov 18, 2024
SYDNEY,Nov. 18,2024-- Activeport Group Ltd (ASX:ATV) has sealed a $4 million perpetual licence agreement with Radian Arc Limited for Activeport\'s cutting-edge cloud gaming software.
Nov 18, 2024
New research highlights key workforce challenges of organisations in Singapore with the vast majority struggling to hire and retain employees
Nov 18, 2024
HANGZHOU,China,Nov. 14,2024-- ZEEKR Intelligent Technology Holding Limited ("ZEEKR" or the "Company") (NYSE: ZK),a global premium electric mobility technology company,today announc
Nov 15, 2024
SINGAPORE,Nov. 14,2024-- BB Energy andSGTraDex renew strategic partnership to advance digital borrowing base financing across Asia. This continued collaboration underscores both companies\' commitment
Nov 15, 2024
Givastomig data presented at ESMO 2024 and SITC 2024 highlights encouraging monotherapy data On track to dose first patient in randomized Phase 2 study ofuliledlimab in first-line mNSCLC in 1H 2025
Nov 15, 2024

© Singapore Technology Information Privacy Policy Contact us